Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Force-Sensing Microbots Designed to Probe Cells

By LabMedica International staff writers
Posted on 23 Oct 2014
Microrobots that have the capability of probing and engineering individual cells and tissue for biological research and medical applications are being constructed with technology that senses the minuscule forces exerted by a robot’s tiny probe. More...


Microrobots small enough to interact with cells already exist. However, there is no easy, inexpensive way to measure the small forces applied to cells by the robots. Measuring these microforces is vital to precisely control the bots and to use them to study cells. “What is needed is a useful tool biologists can use every day and at low cost,” said David Cappelleri, an assistant professor of mechanical engineering at Purdue University (West Lafayette, IN, USA).

Researchers now have devised and constructed a “vision-based micro-force sensor end-effector,” which is attached to the microrobots similar to a tiny proboscis. A camera is used to measure the probe’s displacement while it pushes against cells, allowing a simple calculation that reveals the force applied.

The new strategy could make it possible to easily measure the micronewtons of force applied at the cellular level. Such a tool is needed to better study cells and to understand how they interact with microforces. The forces can be used to convert cells into specific cell lines, including stem cells for research and medical applications. Moreover, the measurement of microforces can be used to examine how cells respond to specific drugs and to diagnose disease.

“You want a device that is low-cost, that can measure micronewton-level forces and that can be easily integrated into standard experimental test beds,” Dr. Cappelleri said. Microrobots used in research are controlled with magnetic fields to move them into place. “But this is the first one with a truly functional end effector to measure microforces,” he said.

The study’s findings were presented during the International Conference on Intelligent Robots and Systems, held in Chicago (IL, USA), September 14–18, 2014.

The new system is combined with the microrobot is about 700 micrometers square, and the researchers are working to create versions about 500 micrometers square. “We are currently working on scaling it down,” Dr. Cappelleri said.

Future research, according to the investigators, also may concentrate on automating the microrobots. The system was fabricated at the Birck Nanotechnology Center in Purdue’s Discovery Park.

Related Links:

Purdue University



Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.